Inventor · disambiguated record
Stefanie Hammer
Also filed as: HAMMER STEFANIE
4 granted patents·13 pending applications·16 citations·filing 2008–2023
71Inventor score
Top patents by PatentIndex Score
17 records- 0195US11478554B2Antibody drug conjugates (ADCS) having enzymatically cleavable groupsBayer Pharma AG·Filed 2021·Granted Oct 25, 2022·5 cites·20 claims
- 0291US11660351B2Antibody drug conjugates (ADCs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2017·Granted May 30, 2023·5 cites·50 claims
- 0389US11071788B2Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBayer Pharma AG·Filed 2016·Granted Jul 27, 2021·6 cites·32 claims
- 0475US2023338559A1Antibody drug conjugates (adcs) having enzymatically cleavable groupsBayer Pharma AG·Filed 2023·Application pending·0 cites
- 0565US2022362392A1Specific antibody drug conjugates (adcs) having ksp inhibitorsBayer Pharma AG·Filed 2022·Application pending·0 cites
- 0661US11433140B2Specific antibody drug conjugates (ADCs) having KSP inhibitorsBayer Pharma AG·Filed 2017·Granted Sep 6, 2022·0 cites·9 claims
- 0750US2021187134A1Combination of pi3k-inhibitors and targeted thorium conjugatesBAYER AS·Filed 2019·Application pending·0 cites
- 0850US2020360531A1Antibody drug conjugates (adcs) with nampt inhibitorsBAYER AG·Filed 2019·Application pending·0 cites
- 0949US2021275686A1Binder/active agent conjugates directed against cxcr5, having enzymatically cleavable linkers and improved activity profileBAYER AG·Filed 2019·Application pending·0 cites
- 1048US2023072421A1Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancerBAYER AS·Filed 2020·Application pending·0 cites
- 1147US2014322220A1Anti-FGFR2 Antibodies and Uses ThereofBAYER IP GMBH·Filed 2012·Application pending·0 cites
- 1247US2015023989A1New antibody drug conjugates (adcs) and the use thereofSEATTLE GENETICS INC·Filed 2012·Application pending·0 cites
- 1346US2009076098A1Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilonesHOFFMANN JENS·Filed 2008·Application pending·0 cites
- 1446US2022125960A1Combination of pd-1/pd-l1 inhibitors and targeted thorium conjugatesBAYER AG·Filed 2020·Application pending·0 cites
- 1545US2022118123A1Combination of ar antagonists and targeted thorium conjugatesBAYER AG·Filed 2020·Application pending·0 cites
- 1643US2016237160A1Anti-tweakr antibodies and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1737US2019298865A1Radio-pharmaceutical complexesBayer Pharma AG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefanie Hammer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →